Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Cornification is the process where living skin cells die to create a protective barrier, and problems with it can cause skin diseases.

Early NAS level changes affect alcohol consumption vulnerability.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Finasteride effectively reduces hair loss by decreasing androgen levels.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

DHT, a testosterone byproduct, causes male pattern baldness.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.